首页> The journal of pathology. Clinical research> Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma.

Post-neoadjuvant assessment of tumour budding according to ITBCC subgroups delivers stage- and regression-grade independent prognostic information in intestinal-type gastric adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Moritz,Jesinghaus

第一单位： Institute of Pathology, University Hospital Marburg, Marburg, Germany.;Institute of Pathology, Technical University Munich, Munich, Germany.

作者： Moritz,Jesinghaus ^[1] ; Anna-Lina,Herz ^[2] ; Meike,Kohlruss ^[2] ; Miguel,Silva ^[2] ; Albert,Grass ^[3] ; Sebastian,Lange ^[4] ; Alexander,Novotny ^[5] ; Katja,Ott ^[6] ; Thomas,Schmidt ^[7] ; Matthias,Gaida ^[8] ; Alexander,Hapfelmeier ^[9] ; Carsten,Denkert ^[3] ; Wilko,Weichert ^[10] ; Gisela,Keller ^[2]

作者单位： Institute of Pathology, University Hospital Marburg, Marburg, Germany.;Institute of Pathology, Technical University Munich, Munich, Germany. ^[1] Institute of Pathology, Technical University Munich, Munich, Germany. ^[2] Institute of Pathology, University Hospital Marburg, Marburg, Germany. ^[3] II Medizinische Klinik, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.;German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany. ^[4] Department of Surgery, Klinikum rechts der Isar, Technical University Munich, Munich, Germany. ^[5] Department of Surgery, Klinikum Rosenheim, Rosenheim, Germany. ^[6] Department of Surgery, University of Heidelberg, Heidelberg, Germany.;Department of Surgery, University Hospital Köln, Köln, Germany. ^[7] Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany. ^[8] Institute of General Practice and Health Services Research, Technical University Munich, Munich, Germany.;Institute for AI and Informatics in Medicine, School of Medicine, Technical University Munich, Munich, Germany. ^[9] Institute of Pathology, Technical University Munich, Munich, Germany.;German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.;Comprehensive Cancer Center Munich (CCCM), Munich, Germany. ^[10]

关键词 gastric adenocarcinoma neoadjuvant therapy prognosis tumour budding

医学主题词腺癌(Adenocarcinoma);人类(Humans);肿瘤辅助疗法(Neoadjuvant Therapy);预后(Prognosis);胃肿瘤(Stomach Neoplasms)

DOI 10.1002/cjp2.284

PMID 35715937

发布时间 2022-10-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交